Clinical Trial Update: Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

Xinlikang Capsule is being studied in Phase 2 and Phase 3 trials for chemotherapy-induced fatigue and immune disorders in patients with diffuse large B-cell lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Xinlikang Capsule

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2, Phase 3 | Status: RECRUITING